drugset / Trial / NCT01211314

Antihypertensive Efficacy of Fixed Combination Drug

NCT01211314

NaSingle-groupOpen-labelTreatment

Summary

Treatment and control of hypertension is still insufficient. About 50% of the patients remain uncontrolled. Lack of compliance with discontinuation of drug treatment is an important reason for not achieving blood pressure. Several studies have shown that use of fixed combinations improve compliance significantly, by reducing the number of pill's intake. This study will assess the antihypertensive efficacy of Vasodip-Combo 20® \[enalapril 20 mg + lercanidipine 10 mg\] as a fixed combination drug in uncontrolled antihypertensive patients.

Timeline

Start
2011-01
Primary completion
2011-12
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Enalapril Other / unclassified 20 mg
Subject Lercanidipine Small molecule 10 mg

Indications